Finding and delivering new drug candidates for treatment.
IDENTIFICATION AND DELIVERY OF CLINICAL DRUG CANDIDATES
This study is all about finding and testing new medicines that could help treat different health conditions, especially for patients looking for better options in cancer care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10281328 on NIH RePORTER |
What this research studies
This research focuses on identifying and delivering promising drug candidates that could be used in clinical settings. It involves conducting various studies necessary for advancing drug discovery projects, particularly within the National Cancer Institute's Experimental Therapeutics Program. Patients may benefit from innovative therapies that emerge from this research as it aims to develop new treatments for various conditions. The approach includes rigorous testing and evaluation of experimental therapeutic agents to ensure their effectiveness and safety.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals with conditions that are currently underserved by existing therapies or those involved in clinical trials for new drug candidates.
Not a fit: Patients with conditions that already have effective treatments or those who do not meet the criteria for the specific drug candidates being tested may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for patients with serious health conditions.
How similar studies have performed: Other research in drug discovery and experimental therapeutics has shown success in developing new treatments, indicating that this approach has potential for meaningful advancements.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Dmitrovsky, Ethan — Leidos Biomedical Research, INC.
- Study coordinator: Dmitrovsky, Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.